Invitation to Attend
Invitation to Attend
In the darkness of June Hobart will once again welcome everyone to the DARK Mofo festival with its famous Winter Feast.
Join us in Hobart for artistic enlightenment and also to illuminate some of the perhaps more impenetrable areas of comprehensive ophthalmic practice – paediatrics and genetics.
As previously two half day scientific sessions will run on Saturday and Sunday mornings, with the GP workshop on Saturday afternoon. Arrive on the Friday night for a welcome reception at story bar and the opportunity to explore the Dark Mofo festival at your leisure. Bring your woollens for the Winter Feast on Saturday Night.
Nude dawn swim is optional.
Accommodation in Hobart will book out very early. Limited rooms have been reserved at the conference venue but please book ASAP.
Dr Guy Bylsma and Prof Alex Hewitt
Organising Commmittee
RANZCO Fellow | $450 AUD |
Senior or Retired Fellow | $280 AUD |
Medical Student | $50 AUD |
Orthoptist | $120 AUD |
Registrar/Junior Doctor | $220 AUD |
Non-Members | $650 AUD |
RANZCO Councillor | $300 AUD |
Accompanying Persons | $200 AUD |
Member | $170 AUD |
Non-Member | $270 AUD |
1 | Novartis | 9 | Johnson & Johnson Surgical Vision |
2 | Credabl | 10 | Ellex | Quantel Medical – Lumibird Medical |
3 | Seqirus | 11 | Bausch & Lomb |
4 | Bayer | 12 | Apellis |
5 | BOQ Specialist | 13 | Avant |
6 | Roche | 14 | Device Technologies |
7 | Carl Zeiss Pty Ltd | 15 | Design For Vision |
8 | Glaukos Australia | 16 | Alcon |
Click on sponsor logos for further information.
We strive to change the practice of medicine. We aspire to approach things differently—to make discoveries that take medicine in new directions. We look to tomorrow to inspire us today. Never satisfied with the status quo, we imagine what’s next.
We are passionate about what we do and the impact we have on patients and societies.
We are Novartis, and we are reimagining medicine
Bausch + Lomb’s surgical division provides the tools and technologies to enable the use of the innovative techniques for the treatment of cataract, corneal, refractive, vitreous and retinal eye conditions.
The company is a global leader in developing state-of-the-art surgical products such as the Stellaris Elite™ combined vitrectomy and phacoemulsification system that allows surgeons to have true “procedural choice”. A full spectrum of intraocular lenses and a large range of instruments through the Bausch+Lomb Storz Ophthalmic Instruments line.
For more information on please contact Bausch + Lomb Customer Service on 1800 251 150 or your Bausch + Lomb Territory Manager.
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
We were the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure that revolutionised the treatment and management of glaucoma. In 2012, we launched our first MIGS device—the iStent®—in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.
In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for glaucoma, corneal health, and retinal diseases.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is located in San Clemente, California, and we have additional locations in 9 regions around the world.
At Glaukos, we are dedicated to addressing the greatest unmet needs of the global ophthalmic market, for physicians and for patients. That’s why we’ve spent more than a decade re-investing in R&D and clinical trial programs to develop and advance a deep pipeline of novel therapies currently being evaluated in FDA clinical trials, while leading the industry in clinical support and patient education resources. And it’s why we’re seeking to leverage our platform technologies to build an unrivaled portfolio of next-generation surgical and pharmaceutical therapies in glaucoma, corneal health, and retinal disease.
We’ve achieved many firsts in clinical studies and over the past several years, Glaukos has reinvested approximately 30% of all sales back into research and development activities – all to relentlessly advance our goal of creating and delivering transformative therapies for patients struggling with eye diseases and the skilled surgeons dedicated to their healing.
We’re proud of the corporate citizenship efforts of the Glaukos Charitable Foundation, Company and employees, and pledge to continue this important work in helping improve the lives of those suffering and in need.
As such, Bayer supports multiple projects and initiatives worldwide as well as partners with ophthalmologists and multiple organisations to improve the lives of people living with a visual impairment or blindness.
As an example, Bayer A.G. launched the Global Ophthalmology Awards Program (GOAP) in 2012 to advance the scientific understanding and clinical management of retinal diseases. Through research and training grants in ophthalmology, the program seeks to provide opportunities for improving therapy and encourage ophthalmologists to further develop skills in treating retinal diseases. Australians have been involved in this initiative since its launch, through providing submissions and also by having a local specialist on the judging committee.
Since the exciting news of Lumibird Medical’s acquisition and merger of Ellex and Quantel Medical, our global focus continues to remain committed to providing innovative world-class technologies. Together Ellex and Quantel Medical have become the world leader in ophthalmology, with a presence in over 110 countries, either directly or via a distributor network – achieving ophthalmic outcomes once never thought possible – safely, effectively, accurately and consistently.
Our range of lasers and ultrasound platforms are designed to diagnose and treat the four main causes of blindness: cataract, glaucoma, diabetic retinopathy and macular degeneration. We also offer a range of devices to diagnose and treat dry eye.
The program overview below is provisional and will be updated as planning proceeds. Please check this page regularly.
Friday 17 June 2022 | |
18:00 – 20:00 | Welcome Reception
Story Bar MACq01 Dress code: Business Casual Join us for a night of networking and catching up with colleagues and friends at the welcome reception for the 2022 Royal Australian and New Zealand College of Ophthalmologists Tasmania Branch Meeting. |
Saturday 18 June 2022 |
|
0830 – 0855 | Registration, Arrival Tea and Coffee – Mezzanine, Level 1 |
Scientific Session – Hotel Grand Chancellor, Harbour View 1 | |
0855 – 0900 | Introduction and Welcome Dr Guy Bylsma, Meeting Convenor, Tasmanian Branch of RANZCO |
Session Chair | Dr Kristin Bell |
0900 – 0930 | Paediatric Update Dr Anu Mathew |
0930 – 1000 | Myopia Dropping Off? Prof James Elder |
1000 – 1030 | Managing Paediatric Glaucoma Dr Jon Ruddle |
1030 – 1100 | Morning Tea – Mezzanine, Level 1 |
Scientific Session – Hotel Grand Chancellor, Harbour View 1 | |
Session Chair | Dr Dean Cugley |
1100 – 1120 | Whose notes are these anyway? – an audit on transferring patient records from one practice to another Dr George Smith |
1120 – 1140 | NF1 screening Ms Navdeep Kaur |
1140 – 1200 | Australian Vision Research Update Mr Phil Cenere |
1200 – 1220 | RANZCO Presidential Update Clinical Professor Nitin Verma AM, RANZCO President |
1220 – 1245 | ANZEF Update Dr John Kennedy |
1245 – 1315 | Lunch – Mezzanine, Level 1 |
1830 – 2130 | Informal Dinner
This year we will not be hosting a formal dinner and instead, we invite you to enjoy the Dark Mofo festival. Dark Mofo, Mona’s midwinter festival in Tasmania, delves into centuries-old winter solstice rituals. Based around the southern hemisphere’s winter solstice, every year we celebrate the dark through large-scale public art, music, fire, food, light and noise. Signature events include the delectable Winter Feast on Hobart’s waterfront. For more information about Dark Mofo please click here |
Sunday 19 June 2022 | |
0730 – 0830 | Annual General Meeting |
0730 – 0850 | Registration, Arrival Tea and Coffee – Mezzanine, Level 1 |
Scientific Session – Hotel Grand Chancellor, Harbour View 1 | |
0850 – 0900 | RANZCO Tasmanian Branch Update Dr Andrew Traill, Secretary, Tasmanian Branch of RANZCO |
Session Chair | Dr Rob McKay |
0900 – 0930 | Retinoblastoma in Australia & Around the World – Screening & Treatment Update Dr Sandra Staffieri |
0930 – 0950 | Genetic Testing in Ophthalmology – Finally? Prof Alex Hewitt |
0950 – 1010 | Curing Batten’s Disease Ms Primrose Mandalawatta & Dr Rajendra KC |
1010 – 1030 | Genetic Correction of Inherited Retinal Diseases Ms Freya Patterson |
1030 – 1100 | Morning Tea |
Scientific Session – Hotel Grand Chancellor, Harbour View 1 | |
Session Chair | Dr Lucy Goold |
1100 – 1130 | Paediatric Red Flags Dr Anu Mathew |
1130 – 1210 | Bruce Hamilton Lecture – The ophthalmology of cerebral palsy A/Prof James Elder |
1210 – 1215 | Meeting Close Prof Alex Hewitt, Tasmanian Branch of RANZCO |
Dear Colleagues,
It is our pleasure to invite you to present at the RANZCO Tasmania Branch Annual Scientific Meeting to be held from 18 – 19 June 2022 in Hobart, Tasmania.
The theme for the meeting this year is the “Paediatrics & Genetics”
There will be a limited number of spots available for oral presentations encompassing Challenging Case Discussion & Audit Presentations on Sunday 19 June.
We encourage submissions addressing all areas of ophthalmology.
Presenters will be allocated 10 mins to present on their topic followed by a 5-minute discussion.
The call for abstracts will close Sunday 5 June 2022, with notification of abstract acceptances distributed the following week.
Accepted presenters will be required to register for the meeting, pay the appropriate registration fee and meet their own travel and accommodation costs.
If you have any questions in relation to the event or submitting an abstract, please contact our meeting secretariat – Conference Design at mail@conferencedesign.com.au.
We look forward to receiving your abstract and the possibility of seeing you in Hobart.
Dr Guy Bylsma
Clinical Professor of Ophthalmology
Meeting Convenor, Tasmanian Branch of RANZCO
Date: Friday 17 June 2022
Time: 6:00pm – 8:00pm
Cost: Inclusive with full registrations.
Day registrations and additional tickets – $65.00 AUD
This year we will not be hosting a formal dinner and instead, we invite you to enjoy the Dark Mofo festival.
Dark Mofo, Mona’s midwinter festival in Tasmania, delves into centuries-old winter solstice rituals. Based around the southern hemisphere’s winter solstice, every year we celebrate the dark through large-scale public art, music, fire, food, light and noise. Signature events include the delectable Winter Feast on Hobart’s waterfront.
For more information about Dark Mofo please click here
The health and safety of all attendees is of utmost importance to RANZCO and the organisers. The conference will follow all COVID-19 guidelines and protocols implemented by the government and host venue. We will work closely with the venue, suppliers, and stakeholders to provide the safest possible environment for conference attendees, and we will continue to monitor and adhere to government advice as planning proceeds.
Please consider that governments and/or venues may require all in-person attendees to be fully vaccinated against COVID-19 and provide proof of vaccination, or valid exemption. We will continue to monitor all requirements, including vaccination, as planning proceeds and advise delegates. We will facilitate changes to your registration if you are impacted at any time.
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) is the medical college responsible for the training and professional development of ophthalmologists in Australia and New Zealand. This includes maintaining a Continuing Professional Development (CPD) system, a Vocational Training Program (VTP), organising scientific congresses and meetings, and much more.
We are the leaders in collaborative eye care – focused on our commitment to:
RANZCO has a three-year Strategic Plan 2021-2023, which aims to build on the College’s successes to date while clearly articulating our vision, mission and strategic priorities.
1 Davey Street
Hobart Tasmania 7000
Australia
When it comes to staying in Hobart, the only place to stay is on the waterfront at Hotel Grand Chancellor Hobart, which features some of the best views in the city. Overlooking the Hobart Harbour and Constitution Dock, this Tasmanian hotel is just steps from popular attractions like Salamanca, Battery Point and the Central Business District, but intimate enough to ensure a perfectly relaxing experience.
conferences.com.au provides delegate registration, website and app solutions, and financial management for conferences, conventions and scientific meetings.
This site uses cookies. Find out more about cookies and how you can refuse them.